Biomea Fusion Inc.

NASDAQ: BMEA · Real-Time Price · USD
2.48
0.93 (60.00%)
At close: Jun 03, 2025, 3:59 PM
2.60
4.63%
After-hours: Jun 03, 2025, 07:59 PM EDT
60.00%
Bid 2.46
Market Cap 93.37M
Revenue (ttm) 1.22M
Net Income (ttm) -99.36M
EPS (ttm) -3.54
PE Ratio (ttm) -0.7
Forward PE -0.95
Analyst Buy
Ask 2.6
Volume 61,800,236
Avg. Volume (20D) 715,553
Open 1.58
Previous Close 1.55
Day's Range 1.52 - 2.65
52-Week Range 1.29 - 13.07
Beta -0.25

About BMEA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BMEA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BMEA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
4 weeks ago
-16.5%
Biomea Fusion shares are trading lower after the c... Unlock content with Pro Subscription
4 months ago
+2.3%
Biomea Fusion shares are trading higher after the company announced new preclinical data from in vivo studies of icovamenib in combination with semaglutide.